Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview

Author(s): Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis, Dimitri P. Mikhailidis

Journal Name: Current Vascular Pharmacology

Volume 12 , Issue 4 , 2014

Become EABM
Become Reviewer


Metabolic syndrome (MetS), a cluster of dyslipidaemia, central obesity, hypertension and/or insulin resistance, is associated with increased cardiovascular disease (CVD) type 2 diabetes risk. Different diagnostic criteria for MetS have been proposed but in 2009 a joint statement by several scientific societies was released.

Apart from the diagnostic criteria, MetS has also been associated with other risk factors including waist to hip ratio, high density lipoprotein dysfunction, small dense low density lipoprotein, postprandial hypertriglyceridaemia, lipoprotein (a), uric acid, liver function tests, prothrombotic factors, cytokines, adipokines, vitamin D, arterial stiffness, renal dysfunction, nephrolithiasis, polycystic ovary syndrome, obstructive sleep apnea.

We discuss the extensive list of MetS-associated factors that may influence vascular risk. Furthermore, we discuss the impact of frequently prescribed drugs (e.g. hypolipidaemic agents) on these variables. These effects may need to be taken into consideration when treating MetS patients.

Keywords: Arterial stiffness, cytokines, diagnostic criteria, lipids, metabolic syndrome, platelets, renal dysfunction, uric acid.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [627 - 641]
Pages: 15
DOI: 10.2174/15701611113119990131
Price: $65

Article Metrics

PDF: 33